Skip to main content

Table 2 Patent information for the drugs used for dementia [21]

From: What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

Generic name Patent name (manufacturer) Drug class Patent expiry
Donepezil Aricept (Eisai  / Pfizer) AChE inhibitor January 2012
Rivastigmine Exelon (Novartis) AChE inhibitor February 2012
Galantamine Reminyl (Shire) AChE inhibitor July 2012
Memantine Ebixa (Lundbeck) NMDA receptor antagonist April 2014
  1. AChE Acetylcholinesterase, NMDA N-methyl-d-aspartate